PPT-Engaging Individuals with an Opioid Use Disorder (OUD) David Loveland, Ph.D.
Author : pasty-toler | Published Date : 2019-11-03
Engaging Individuals with an Opioid Use Disorder OUD David Loveland PhD Community Care 2017 Community Care Behavioral Health Organization Questions to Consider
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Engaging Individuals with an Opioid Use ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Engaging Individuals with an Opioid Use Disorder (OUD) David Loveland, Ph.D.: Transcript
Engaging Individuals with an Opioid Use Disorder OUD David Loveland PhD Community Care 2017 Community Care Behavioral Health Organization Questions to Consider 1 2 Could you effectively engage individuals with an OUD in treatment soon after they had recovered from an overdose and could you do it for as low as 500 a day. John e lopes . j. r. .. , . dhs. c. , pa-c. A. ssociate Professor, . Physician Assistant Program. Central Michigan University. and . Project Director. Medication-assisted Treatment Waiver Training Initiative. A . Roadmap for Care Providers. Davina Moss-King, Ph.D.. Positive Direction and Associates, Inc.. March 17, 2018. 1. Some Information Adapted from ACOG District II Presentation Opioid Use Disorder Bundle, 2018. . Learning Objectives:. Identify the impact of opioid use, addiction, and recovery on child development. Identify warning signs of opioid . use and abuse. Discuss the five components of recovery. PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine. Assessing Opioid Use Disorder, part . 2. Objectives. Identify key features of opioid use disorder.. Understand . the evaluation of opioid use disorder in the setting of chronic pain.. (Opioid STR). Pre-Application Technical Assistance. December 21, 2016. 3:00 pm to 4:30 pm EST. Housekeeping. 3. Housekeeping (cont’d.). 4. Welcome and Overview. SAMHSA Participants . Kimberly Johnson, PhD., Director, CSAT. Angeline Stanislaus, MD. Chief Medical director- adult services. Missouri . Dept. of Mental Health. How many people are dying each day?. 115. Overdoses. Missouri- Total number of opioid related death 2017. and . M. edication . Assisted Treatment . and . Team . Training in . Rural . Colorado. Behavioral Health Provider Training. Module 3: . Pharmacology of Buprenorphine and Other Drugs. Copyright 2018 Regents of the University of Colorado. All Rights Reserved. ri ze massachusetts AUTHORS: Caroline DavidsonChetna Bansal Shannon Hartley PAGE 2 | OPPORTUNITIES TO INCREASE SCREENING & TREATMENT OF OUD AMONG HEALTHCARE PROFESSIONALS 2019 SHATTERPROOF PAGE 2 | OP Joshua Blum MD. April 7, 2018. No relevant financial disclosures. Learning objectives. Utilize the latest evidence around opioid-induced hyperalgesia to mitigate negative consequences . Implement best practices around opioid rotation to manage OIH. William J. Lorman, JD, PhD, MSN, PMHNP-BC, CARN-AP. V. P. & Chief Clinical Officer, Livengrin Foundation, Inc.. Ass’t. Clinical Professor, Doctoral Nursing Dept., . Drexel University. wlorman@livengrin.org. an increase in the number of cases of a disease above what is normally expected in that area. injury to the body (poisoning) that happens when a drug is taken in excessive amounts. when a person’s use of drugs or alcohol results in health issues or problems in their work, school, or home life; commonly called addiction. Brian Grahan, MD, PhD. Addiction Medicine / Internal Medicine. 6/7/2018. Disclosures. This educational initiative is funded by a grant from the Minnesota Department of Human Services. I have no financial interests to disclose. . Farinaz . Khan, . Paul . Romo, MD. Disclosure. None. Outline. Opioids and the Neuroendocrine system. Misuse and Addiction. Treatment . Special Populations- forensics. Objective. By the end of this didactic, you will be able to:. Research . designs, methods, and study execution . Michael C. Rowbotham, MD. Chief Research Officer, Sutter Health. Adjunct Professor, UCSF Anesthesia. Professor Emeritus, UCSF Neurology. What does ‘opioid sparing’ mean and what are the...
Download Document
Here is the link to download the presentation.
"Engaging Individuals with an Opioid Use Disorder (OUD) David Loveland, Ph.D."The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents
